Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chantal Laframboise"'
Autor:
Nikhil Chauhan, Mary F Mulcahy, Riad Salem, Al B Benson III, Eveline Boucher, Janet Bukovcan, David Cosgrove, Chantal Laframboise, Robert J Lewandowski, Fayaz Master, Bassel El-Rayes, Jonathan R Strosberg, Daniel Y Sze, Ricky A Sharma
BACKGROUND Colorectal cancer is one of the most common cancers and causes of cancer-related death. Up to approximately 70% of patients with metastatic colorectal cancer (mCRC) have metastases to the liver at initial diagnosis. Second-line systemic tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cea89079055cab7a5df0a68b37aa93c
https://doi.org/10.2196/preprints.11545
https://doi.org/10.2196/preprints.11545
Autor:
Mary F. Mulcahy, Al B. Benson, Chantal Laframboise, David Cosgrove, Jonathan R. Strosberg, Robert J. Lewandowski, Eveline Boucher, Bassel F. El-Rayes, Fayaz Master, Daniel Y. Sze, Nikhil Chauhan, Riad Salem, Janet Bukovcan, Ricky A. Sharma
Publikováno v:
JMIR Research Protocols
Background: Colorectal cancer is one of the most common cancers and causes of cancer-related death. Up to approximately 70% of patients with metastatic colorectal cancer (mCRC) have metastases to the liver at initial diagnosis. Second-line systemic t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d5da964add7ed9774c772d6f2f66c8
https://pubmed.ncbi.nlm.nih.gov/30664496
https://pubmed.ncbi.nlm.nih.gov/30664496
Autor:
Mary Louise Morris, Julie A. Lekstrom-Himes, Arthur M. Krieg, Heather L. Davis, Philip Leese, Chantal Laframboise, Alain Vicari, Mohammed J Al-Adhami, Susan M. Efler, Tess Schmalbach
Publikováno v:
Antiviral Therapy. 12:741-751
CPG 10101 (ACTILON™) is a novel potent and selective unmethylated cytidine-phosphate-guanosine (CpG)-containing oligodeoxynucleotide agonist of Toll-like receptor 9 (TLR9) being developed for the treatment of chronic infections such as HCV.Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::361bf1720f203cb76d0327921c25bbf7
https://doi.org/10.1177/135965350701200501
https://doi.org/10.1177/135965350701200501
Autor:
Alain P, Vicari, Tess, Schmalbach, Julie, Lekstrom-Himes, Mary Louise, Morris, Mohammed J, Al-Adhami, Chantal, Laframboise, Philip, Leese, Arthur M, Krieg, Susan M, Efler, Heather L, Davis
Publikováno v:
Antiviral therapy. 12(5)
CPG 10101 (ACTILON) is a novel potent and selective unmethylated cytidine-phosphate-guanosine (CpG)-containing oligodeoxynucleotide agonist of Toll-like receptor 9 (TLR9) being developed for the treatment of chronic infections such as HCV.In this ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86b41dc6aab83b3907009b997c9dae76
https://pubmed.ncbi.nlm.nih.gov/17713157
https://pubmed.ncbi.nlm.nih.gov/17713157